Univo Pharmaceuticals Ltd. Logo

Univo Pharmaceuticals Ltd.

Vertically integrated biopharma firm developing medical cannabis treatments with a focus on CNS.

UNVO-M | TA

Overview

Corporate Details

ISIN(s):
IL0010935588
LEI:
Country:
Israel
Address:
30 Haarbaa TEL AVIV-JAFFA, Central District, 6473926 Tel Aviv
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Univo Pharmaceuticals Ltd. is a vertically integrated biopharmaceutical company operating in the medical cannabis sector. The company manages the entire value chain, from research, development, and cultivation to the manufacturing and distribution of cannabis-based medical products. By maintaining full control over its processes, Univo aims to develop high-quality solutions to improve patient health and quality of life. The firm has a particular focus on developing treatments for the central nervous system (CNS) and operates a significant distribution network, supplying its products to numerous pharmacies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-08-10 19:49
Regulatory News Service
ISA informed TASE that the company is a "shell company", the company's securiti…
Hebrew (modern) 81.2 KB
2022-12-18 14:53
Regulatory News Service
Trading in the company's shares has been suspended as of today, on December 28…
Hebrew (modern) 80.0 KB
2022-12-12 11:07
Regulatory News Service
BOND SERIES A-TRADING SUSPENSION FOLLOWING TRUSTEE ANNOUNCEMENT REGARDING IMMED…
Hebrew (modern) 77.4 KB
2022-07-21 19:42
Regulatory News Service
Discontinuation of Market Making, If another market maker will not start to op…
Hebrew (modern) 255.5 KB

Automate Your Workflow. Get a real-time feed of all Univo Pharmaceuticals Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Univo Pharmaceuticals Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.